Multiple studies propose PCP4 as a novel prognostic biomarker for cancers, including lung adenocarcinoma (15), PCa (16), thyroid carcinoma (17) and testicular germ cell tumors (18). Here, PCP4 is linked to posterior cortical atrophy.